HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
暂无分享,去创建一个
Yuen-Li Chung | W Marston Linehan | W. Linehan | B. Zbar | L. Neckers | P. Ratcliffe | W. Linehan | J. Toro | J. Isaacs | J. Trepel | Yun-jin Jung | D. Mole | Maria J. Merino | Sunmin Lee | Yuen-Li Chung | Yunjin Jung | Len Neckers | Berton Zbar | Peter J Ratcliffe | David R Mole | Jorge Toro | Carlos Torres-Cabala | Jennifer S Isaacs | Sunmin Lee | Jane Trepel | Yun Jin Jung | Maria Merino | C. Torres-Cabala | Maria J Merino | C. Torres‐Cabala
[1] R. Klausner,et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] Jessica Lo,et al. HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .
[3] Richard A. Roth,et al. Regulation of GLUT1 Gene Transcription by the Serine/Threonine Kinase Akt1* , 1999, The Journal of Biological Chemistry.
[4] A. Munnich,et al. Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. , 1994, The Journal of clinical investigation.
[5] N P Burrows,et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. , 2003, Human molecular genetics.
[6] P. Ratcliffe,et al. Leu‐574 of human HIF‐1α is a molecular determinant of prolyl hydroxylation , 2004 .
[7] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[8] A. Kibel,et al. Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.
[9] P. Choyke,et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.
[10] G. Semenza,et al. Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.
[11] J. Brooks,et al. Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.
[12] M. Ivan,et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.
[13] Mirna Lechpammer,et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. , 2002, Cancer cell.
[14] Ulrich Müller,et al. Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.
[15] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .
[16] W. Kaelin,et al. Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth , 2003, PLoS biology.
[17] M. Hatch. A simple spectrophotometric assay for fumarate hydratase in crude tissue extracts. , 1978, Analytical biochemistry.
[18] L. Neckers,et al. Aryl Hydrocarbon Nuclear Translocator (ARNT) Promotes Oxygen-independent Stabilization of Hypoxia-inducible Factor-1α by Modulating an Hsp90-dependent Regulatory Pathway* , 2004, Journal of Biological Chemistry.
[19] S. McKnight,et al. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.
[20] Charis Eng,et al. A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.
[21] L. Aaltonen,et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. , 2004, American journal of human genetics.
[22] C. Schofield,et al. A fluorescence-based assay for 2-oxoglutarate-dependent oxygenases. , 2005, Analytical biochemistry.
[23] John L Cleveland,et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.
[24] M. Schindl,et al. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.
[25] D. J. Porter,et al. 3-Carbanionic substrate analogues bind very tightly to fumarase and aspartase. , 1980, The Journal of biological chemistry.
[26] L. Aaltonen,et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. , 2001, The American journal of pathology.
[27] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[28] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[29] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[30] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.
[31] R. Poulsom,et al. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome , 2005, The Journal of pathology.
[32] Christopher J. Schofield,et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL , 2002, Nature.
[33] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Choyke,et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer , 2005, Journal of Medical Genetics.
[35] J. L. Rosa,et al. 6-Phosphofructo-2-kinase (pfkfb3) Gene Promoter Contains Hypoxia-inducible Factor-1 Binding Sites Necessary for Transactivation in Response to Hypoxia* , 2004, Journal of Biological Chemistry.
[36] Richard D Klausner,et al. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. , 2002, Cancer cell.
[37] L. Liotta,et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. , 1995, The American journal of pathology.
[38] G. Semenza,et al. Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.
[39] J. Pouysségur,et al. HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.
[40] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[41] A. Harris,et al. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. , 2003, Cancer research.
[42] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[43] S. Richard,et al. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. , 1997, American journal of human genetics.
[44] Fahmeed Hyder,et al. Energetic basis of brain activity: implications for neuroimaging , 2004, Trends in Neurosciences.
[45] S. White,et al. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[47] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[48] O. Hankinson,et al. The Role of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) in Hypoxic Induction of Gene Expression , 1996, The Journal of Biological Chemistry.
[49] W. Kaelin,et al. The VHL tumour-suppressor gene paradigm. , 1998, Trends in genetics : TIG.
[50] L. Neckers,et al. Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative Pathway* , 2002, The Journal of Biological Chemistry.
[51] L. Aaltonen,et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] W. Kaelin,et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.
[53] H. Gröne,et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. , 2001, Cancer research.
[54] D. Edmondson,et al. Inactivation of succinate dehydrogenase by 3-nitropropionate. , 1979, The Journal of biological chemistry.
[55] P. Ratcliffe,et al. Determination and comparison of specific activity of the HIF‐prolyl hydroxylases , 2004, FEBS letters.
[56] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[57] U. Thorgeirsson,et al. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. , 2000, Biochemical and biophysical research communications.
[58] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[59] M. Zeviani,et al. Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes , 1990, Neurology.
[60] M. Gassmann,et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.
[61] N. Sang,et al. Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.
[62] E S Husebye,et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.